GNRH1 and polycystic ovary syndrome: By demonstrating that AR is expressed in tanycytes and linking this expression to functional outcomes (such as altered GnRH/LH secretion), our study provides valuable insights into PCOS clinical interventions by showing that inhibiting AR activity may rectify functional abnormalities in the GnRH-tanycyte unit.